ArticleFrontiers in oncology2025
Focal nodular hyperplasia combined with hepatocellular carcinoma with bone metastasis: a case report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Focal nodular hyperplasia (FNH), the second most common benign liver lesion, is widely regarded as having no malignant potential. This study reports a 29-year-old male who was admitted to the hospital due to a space-occupying liver lesion accompanied by low back pain. Abdominal contrast-enhanced computed tomography (CE-CT) suggested FNH. The patient underwent surgical treatment, and postoperative pathological results revealed both FNH and hepatocellular carcinoma (HCC). The patient still experienced low back pain symptoms after surgery. He was later confirmed to have bone metastasis (BM) and received radiotherapy. Cases combining FNH and HCC are extremely rare, particularly when accompanied by metastasis. This study aims to report a case of FNH combined with HCC and accompanied by BM, and to review its treatment process in detail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.